Strong Revenue Growth:
Available evidence indicates revenue has risen rapidly, including reported year-over-year growth above 130% and approximately $200 million in annual recurring revenue as of May 2026. The company also describes revenue more than doubling for five consecutive years, signaling accelerating top-line momentum.
Investor Backing & Capital Strength:
Successive late-stage rounds in 2026 raised roughly $218 million and lifted the reported valuation from about $1.35 billion to $2.74 billion within months. This pattern points to substantial capital access and confidence from prominent investors.
Strategic Partnerships:
Partnerships with organizations such as Mercy, Atlantic Health, Teladoc Health, Marathon Health, and Priority Health are described as expanding distribution and embedding the product within provider and health-plan channels. These relationships broaden commercial reach beyond direct employer sales.
